Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas R Brook

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
JBI Database of Systematic Reviews and Implementation Reports|June 20, 2017
Identifying predictors of change in the severity of untreated lower urinary tract symptoms in men: a systematic review protocolSimon J D Harley, Gary Wittert, Nicholas R Brook, et al.
Asian Journal of Urology|November 29, 2023
Clinical outcomes for men with positive surgical margins after radical prostatectomy-results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registryKerri R Beckmann, Michael E O'Callaghan, Andrew D Vincent, et al.
ANZ Journal of Surgery|February 2, 2019
Malignant mesothelioma of the tunica vaginalis: a atypical presentation of a rare scrotal tumourMark C Harris, Callum Logan, Andrew Chetwood, et al.
Clinical Transplantation|November 2, 2004
A report on the activity and clinical outcomes of renal non-heart beating donor transplantation in the United KingdomNicholas R Brook, Julian R Waller, Amanda C Richardson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 12, 2010
Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risksNatasha M Rogers, Hooi S Eng, Raymond Yu, et al.
Sleep Health|July 16, 2017
Erectile dysfunction is independently associated with apnea-hypopnea index and oxygen desaturation index in elderly, but not younger, community-dwelling menSean A Martin, Sarah L Appleton, Robert J Adams, et al.
BJU International|February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trialShankar Siva, Daniel Pham, Tomas Kron, et al.
BMC Cancer|October 25, 2018
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK IIShankar Siva, Brent Chesson, Mathias Bressel, et al.
The Lancet. Oncology|February 29, 2024
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trialShankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet. Oncology|May 17, 2026
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 studyShankar Siva, David Pryor, Jarad Martin, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
JBI Database of Systematic Reviews and Implementation Reports|June 20, 2017
Identifying predictors of change in the severity of untreated lower urinary tract symptoms in men: a systematic review protocolSimon J D Harley, Gary Wittert, Nicholas R Brook, et al.
Asian Journal of Urology|November 29, 2023
Clinical outcomes for men with positive surgical margins after radical prostatectomy-results from the South Australian Prostate Cancer Clinical Outcomes Collaborative community-based registryKerri R Beckmann, Michael E O'Callaghan, Andrew D Vincent, et al.
ANZ Journal of Surgery|February 2, 2019
Malignant mesothelioma of the tunica vaginalis: a atypical presentation of a rare scrotal tumourMark C Harris, Callum Logan, Andrew Chetwood, et al.
Clinical Transplantation|November 2, 2004
A report on the activity and clinical outcomes of renal non-heart beating donor transplantation in the United KingdomNicholas R Brook, Julian R Waller, Amanda C Richardson, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 12, 2010
Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risksNatasha M Rogers, Hooi S Eng, Raymond Yu, et al.
Sleep Health|July 16, 2017
Erectile dysfunction is independently associated with apnea-hypopnea index and oxygen desaturation index in elderly, but not younger, community-dwelling menSean A Martin, Sarah L Appleton, Robert J Adams, et al.
BJU International|February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trialShankar Siva, Daniel Pham, Tomas Kron, et al.
BMC Cancer|October 25, 2018
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK IIShankar Siva, Brent Chesson, Mathias Bressel, et al.
The Lancet. Oncology|February 29, 2024
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trialShankar Siva, Mathias Bressel, Mark Sidhom, et al.
The Lancet. Oncology|May 17, 2026
Long-term outcomes of stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a multicentre, non-randomised, phase 2 studyShankar Siva, David Pryor, Jarad Martin, et al.
Pageof 3